American Renal Associates Holdings, Inc.

American Renal Associates Holdings, Inc. (ARA) relating to its acquisition by Nautic Partners, LLC. Under the terms of the agreement, ARA shareholders shall be entitled to receive $11.50 in cash for each share of ARA common stock owned.

Seacoast Commerce Banc Holdings

Seacoast Commerce Banc Holdings (SCBH) related to the merger agreement with Enterprise Financial Services Corp. Under the terms of the merger agreement, the company will be acquired by Enterprise, and Seacoast stockholders will receive 0.5061 shares of Enterprise common stock for each share of Seacoast common stock owned.

Hennessy Capital Acquisition Corp. IV

Hennessy Capital Acquisition Corp. IV. (HCAC) related to the merger agreement with Canoo Holdings, Ltd. Under the terms of the merger agreement, the company will acquire Canoo through a reverse merger that will result in Canoo becoming a publicly-listed company.

Virtusa Corporation

Virtusa Corporation (VRTU) related to its sale to Baring Private Equity Asia. Under the terms of the agreement, Virtusa shareholders will receive $51.35 per share for each share of Virtusa stock owned.

Trine Acquisition Corp.

Trine Acquisition Corp, Inc. (TRNE) related to the busienss combination with Desktop Metal for its 3D printing business.

Aimmune Therapeutics, Inc.

Aimmune Therapeutics, Inc. (AIMT) related to its sale to Sociétés des Produits Nestlé, S.A. Under the terms of the agreement, Aimmune shareholders will receive $34.50 per share for each share of Aimmune stock owned.

Immunomedics, Inc.

Immunomedics, Inc. (IMMU) related to its sale to Gilead Sciences, Inc. Under the terms of the agreement, Immunomedics shareholders will receive $88.00 per share for each share of Immunomedics stock owned.

BMC Stock Holdings, Inc.

BMC Stock Holdings, Inc. (BMCH) related to its sale to Builders First Source, Inc. Under the terms of the agreement, BMC shareholders will receive 1.3125 shares of Builder First Source stock for each share of BMC stock owned.

Akcea Therapeutics, Inc.

Akcea Therapeutics, Inc. (AKCA) related to its sale to Ionis Pharmaceuticals, Inc. Under the terms of the agreement, Akcea shareholders will receive $18.15 in cash for each share of Akcea common stock owned.

Rosetta Stone Inc.

Rosetta Stone Inc. (RST) related to its sale to Cambium Learning Group. Under the terms of the agreement, Rosetta Stone shareholders will receive $30 in cash for each share of Rosetta Stone stock owned.